Home Featured Page 244

Featured

Latest

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

atai Life Sciences Announces Launch of Initial Public Offering

Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit...

Red Light Holland Closes Acquisition of 80% of Happy Caps Mushroom...

PharmaTher Provides Research and Development Update and Milestones for 2021

MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder...

Filament Cultivates 20th Psychedelic Mushroom Variety and Provides Propagation Update

MindMed Announces Chief Executive Officer Transition

Accountability & Transformative Justice in the Psychedelic Space: A Roadmap for...

Awakn Life Sciences Completes Previously Announced Private Placement For Gross Proceeds...

1...243244245...301 Page 244 of 301

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

atai Life Sciences Announces Launch of Initial Public Offering

LSD and the Anarchic Brain

Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit...

Red Light Holland Closes Acquisition of 80% of Happy Caps Mushroom...

PharmaTher Provides Research and Development Update and Milestones for 2021

MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder...

Filament Cultivates 20th Psychedelic Mushroom Variety and Provides Propagation Update

MindMed Announces Chief Executive Officer Transition

Accountability & Transformative Justice in the Psychedelic Space: A Roadmap for...

Awakn Life Sciences Completes Previously Announced Private Placement For Gross Proceeds...

EDITOR PICKS

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY